INTERNATIONAL PATENT: YISSUM RESEARCH DEVELOPMENT COMPANY OF THE HEBREW UNIVERSITY OF JERUSALEM LTD., HADASIT MEDICAL RESEARCH SERVICES & DEVELOPMENT LTD. FILES APPLICATION FOR "CALRETICULIN PEPTIDOMIMETIC INHIBITORS AND PRODRUGS"

GENEVA, July 8 -- YISSUM RESEARCH DEVELOPMENT COMPANY OF THE HEBREW UNIVERSITY OF JERUSALEM LTD. (Hi Tech Park, Edmond J. Safra CampusGivat Ram, POB 391359139002 Jerusalem), HADASIT MEDICAL RESEARCH SERVICES & DEVELOPMENT LTD. (Jerusalem BioPark, Hadassah Ein Kerem Medical CenterP.O.B. 120009112001 Jerusalem) filed a patent application (PCT/IL2024/051221) for "CALRETICULIN PEPTIDOMIMETIC INHIBITORS AND PRODRUGS" on Dec 25, 2024. With publication no. WO/2025/141573, the details related to the patent application was published on Jul 03, 2025.

Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).

Inventor(s): HOFFMAN, ...